(Q44103854)

29 November 2017

An immunohistochemical study of bcl-2 and p53 protein expression in pancreatic carcinomas (English)

1 reference

29 November 2017

1 reference

Ohshio G

1

1 reference

29 November 2017

Suwa H

2

1 reference

29 November 2017

Imamura T

3

1 reference

29 November 2017

Yamaki K

4

1 reference

29 November 2017

Tanaka T

5

1 reference

29 November 2017

Hashimoto Y

6

1 reference

29 November 2017

Imamura M

7

1 reference

29 November 2017

1 May 1998

1 reference

Scandinavian Journal of Gastroenterology

29 November 2017

1 reference

29 November 2017

33

1 reference

29 November 2017

5

1 reference

29 November 2017

535-539

1 reference

Programmed cell death: apoptosis and oncogenesis.

29 November 2017

1 reference

https://api.crossref.org/works/10.1080%2F00365529850172124

bcl-2 protein in non-small-cell lung carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365529850172124

The Bcl-2 protein: a prognostic indicator strongly related to p53 protein in lymph node-negative breast cancer patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365529850172124

Mutations in the p53 gene occur in diverse human tumour types

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365529850172124

Clinical significance of serum p53 antigen in patients with pancreatic carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365529850172124

Apoptotic cell death induced by c-myc is inhibited by bcl-2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365529850172124

DNA damage can induce apoptosis in proliferating lymphoid cells via p53-independent mechanisms inhibitable by Bcl-2

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365529850172124

10.1080/00365529850172124

21 January 2018

Identifiers

DOI

1 reference

29 November 2017

1 reference